Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sophie Prodinger
Histone Deacetylase Inhibitors Valproic Acid and Vorinostat Enhance Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Phagocytosis
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation
Cancer Research
Cancer Research
Oncology
Anti-Kl-6/Muc1 Monoclonal Antibody Reverses Resistance to Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity by Capping MUC1
Cancer Letters
Cancer Research
Oncology
Histone Deacetylase Inhibitor, Valproic Acid, Radiosensitizes the C6 Glioma Cell Line in Vitro
Oncology Letters
Cancer Research
Oncology
Histone Deacetylase 9 Deficiency Protects Against Effector T Cell-Mediated Systemic Autoimmunity
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat
Pharmacotherapy
Pharmacology
Histone Deacetylase Inhibitors Modulate Interleukin 6-Dependent CD4+T Cell Polarizationin Vitroandin Vivo
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Histone Deacetylase Inhibition by Valproic Acid Down-Regulates C-Flip/Cash and Sensitizes Hepatoma Cells Towards CD95- And TRAIL Receptor-Mediated Apoptosis and Chemotherapy
Oncology Reports
Medicine
Cancer Research
Oncology
Histone Deacetylase Inhibitors Valproic Acid and Depsipeptide Sensitize Retinoblastoma Cells to Radiotherapy by Increasing H2AX Phosphorylation and P53 Acetylation-Phosphorylation
International Journal of Oncology
Cancer Research
Oncology
Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors
Journal of Biomedicine and Biotechnology
